Credit Agricole’s AbCellera Biologics ABCL Stock Holding History

Credit Agricole’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$14.7K	Hold	6,600	–	–	﹤0.01%	1203
2024 Q4	$19.3K	Hold	6,600	–	–	﹤0.01%	1214
2024 Q3	$17.2K	Hold	6,600	–	–	﹤0.01%	1196
2024 Q2	$19.5K	Hold	6,600	–	–	﹤0.01%	1035
2024 Q1	$25.8K	Hold	6,600	–	–	﹤0.01%	825
2023 Q4	$37.7K	Sell	6,600 -3,000	-31%	-$13.9K	﹤0.01%	798
2023 Q3	$44.2K	Hold	9,600	–	–	﹤0.01%	794
2023 Q2	$62K	Hold	9,600	–	–	﹤0.01%	518
2023 Q1	$72.4K	Hold	9,600	–	–	﹤0.01%	472
2022 Q4	$97.2K	Hold	9,600	–	–	﹤0.01%	463
2022 Q3	$95K	Hold	9,600	–	–	﹤0.01%	460
2022 Q2	$102K	Hold	9,600	–	–	﹤0.01%	457
2022 Q1	$94K	Hold	9,600	–	–	﹤0.01%	484
2021 Q4	$137K	Buy	9,600 +3,000	+45%	+$45.5K	﹤0.01%	446
2021 Q3	$132K	Buy	+6,600	New	+$117K	﹤0.01%	421

Other funds holding ABCL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Credit Agricole's ABCL Position: Q1 2025 in Review

Credit Agricole held its AbCellera Biologics (ABCL) position steady in Q1 2025 at 6,600 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1203.

Credit Agricole first reported a position in ABCL in Q3 2021 and has held it in 15 quarters since. The position peaked at $137K in Q4 2021. 129 funds tracked by Wall St. Rank hold ABCL as of Q1 2025.

Credit Agricole held 6,600 shares of AbCellera Biologics worth $14.7K as of Q1 2025.
Credit Agricole left its AbCellera Biologics share count unchanged in Q1 2025.
AbCellera Biologics made up ﹤0.01% of Credit Agricole's portfolio in Q1 2025, its #1203 holding.
Credit Agricole first reported a position in AbCellera Biologics in Q3 2021 and has held it in 15 quarters since.
Credit Agricole's AbCellera Biologics position peaked at $137K in Q4 2021.
129 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2025.

Based on Credit Agricole's 13F filing for Q1 2025, filed 14 May 2025.